We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
ClinicalTrials.gov Menu

HEALEY ALS Platform Trial - Regimen E SLS-005 - Trehalose

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT05136885
Recruitment Status : Enrolling by invitation
First Posted : November 29, 2021
Last Update Posted : May 17, 2023
Seelos Therapeutics, Inc.
Information provided by (Responsible Party):
Merit E. Cudkowicz, MD, Massachusetts General Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : August 2023
Estimated Study Completion Date : September 2023